Tag: Molecular Biology Innovation Award

Nandana Shaji | Molecular Biology | Best Researcher Award

Published on by World Science Awards

Best Researcher Award

Nandana Shaji
Affiliation SRM Institute of Science and Technology
Country India
Subject Area Molecular Biology
Event World Science Awards
ORCID 0009-0005-2169-9329

Nandana Shaji

SRM Institute of Science and Technology

The Best Researcher Award recognizes academic excellence through scholarly integrity, research innovation, scientific contribution, and professional engagement within specialized disciplines. Nandana Shaji is associated with SRM Institute of Science and Technology and conducts academic work in the field of Molecular Biology. This article provides a neutral overview of the research profile based on the available institutional and researcher information while considering the general evaluation principles commonly applied in international academic recognition programs.[1]

Abstract

This article presents an academic overview of Nandana Shaji in relation to the Best Researcher Award at the World Science Awards. The profile highlights institutional affiliation, research specialization, scholarly relevance, and professional contributions within Molecular Biology. In the absence of publicly provided bibliometric indicators, the discussion focuses on research discipline, scientific engagement, and the broader importance of molecular biology research while maintaining a neutral and evidence-based academic perspective.[1]

Keywords

  • Best Researcher Award
  • Molecular Biology
  • Biomedical Research
  • Scientific Innovation
  • Academic Excellence
  • Research Evaluation

Introduction

Molecular Biology is a foundational scientific discipline that investigates the molecular mechanisms governing living organisms. Advances within this field contribute to genetics, biotechnology, medicine, drug discovery, precision healthcare, and diagnostic innovation. Contemporary molecular biology research frequently integrates computational approaches, laboratory experimentation, and interdisciplinary collaboration to address complex biological challenges. Recognition through academic awards encourages continued scientific excellence and promotes impactful research across the life sciences.[2]

Research Profile

Nandana Shaji is affiliated with SRM Institute of Science and Technology, India, and is associated with research in Molecular Biology. The available public researcher information includes an authenticated ORCID profile, which supports transparent researcher identification and facilitates attribution of scholarly activities. While detailed bibliometric indicators are not publicly supplied within the available information, institutional affiliation and ORCID registration demonstrate commitment to recognized academic research practices.[1]

Research Contributions

Research within Molecular Biology contributes to understanding cellular function, gene regulation, protein interactions, molecular diagnostics, and disease mechanisms. Such investigations provide scientific foundations for translational medicine, biotechnology, and biomedical innovation. Researchers working in this area support the advancement of evidence-based scientific knowledge through experimentation, collaboration, and publication within peer-reviewed academic literature.[2]

  • Research associated with Molecular Biology.
  • Participation in scientific investigation and academic learning.
  • Contribution to interdisciplinary biomedical research.
  • Support for evidence-based scientific advancement.

Publications

Specific publication metrics are not included within the supplied researcher information. Nevertheless, scholarly publication remains an essential mechanism for disseminating research findings, encouraging scientific collaboration, and facilitating independent verification of experimental results. Publications indexed in internationally recognized databases contribute to academic visibility and research evaluation.[2]

Research Impact

The impact of Molecular Biology research extends across healthcare, pharmaceuticals, biotechnology, genetics, agriculture, and environmental sciences. Academic influence is commonly assessed using peer-reviewed publications, citation analysis, collaborative research, and reproducible scientific outcomes. Although detailed bibliometric information is unavailable in the supplied profile, continued engagement within this discipline supports long-term scientific development and innovation.[2]

Award Suitability

Eligibility for the Best Researcher Award is generally evaluated through academic integrity, research originality, scholarly dissemination, institutional contribution, and scientific relevance. Based on the available information, Nandana Shaji demonstrates recognized institutional affiliation, an established ORCID researcher identity, and specialization within Molecular Biology. These characteristics are consistent with the transparent and evidence-based evaluation principles commonly adopted by international academic award programs.[1][2]

Conclusion

Nandana Shaji represents an academic profile associated with Molecular Biology at SRM Institute of Science and Technology. The available researcher information reflects participation within an important scientific discipline that contributes to biomedical knowledge and innovation. The profile aligns with the principles of scholarly recognition by emphasizing scientific inquiry, professional development, institutional affiliation, and transparent researcher identification through ORCID.[1]

References

  1. ORCID. (n.d.). Researcher Profile: Nandana Shaji, ORCID 0009-0005-2169-9329.
    https://orcid.org/0009-0005-2169-9329
  2. Nature Reviews Molecular Cell Biology. General reference describing Molecular Biology research, scientific methodologies, and advances in life science.
    https://www.nature.com/nrm/
  3. Nature. Example DOI reference illustrating Molecular Biology citation format.
    https://doi.org/10.1038/s41586-020-2649-2

Kazunari K (kazushige) Yokoyama | Molecular Biology | Best Researcher Award

Published on by World Science Awards

Best Researcher Award

Kazunari K (kazushige) Yokoyama
Affiliation Kaohsiung Medical University
Country Taiwan
Scopus ID 7401877315
Documents 241
Citations 8,317
h-index 52
Subject Area Molecular Biology, Genetics, Cancer Biology, Stem Cell Research
Event World Science Awards
ORCID 0000-0001-8508-7587

Kazunari K (kazushige) Yokoyama
Kaohsiung Medical University, Taiwan

Kazunari K. Yokoyama, officially known as Kazushige Yokoyama, is a distinguished molecular biologist, geneticist, and biomedical researcher whose scientific contributions have significantly influenced the fields of transcription factor biology, chromatin remodeling, stem cell research, cancer biology, oxidative stress, and gene regulation. His academic career spans more than four decades across leading institutions in Japan, the United States, France, China, and Taiwan. Through pioneering studies on AP-1 transcription factors, JDP2 signaling, antisense nucleic acid technologies, and stem-cell-associated molecular mechanisms, he has established an internationally recognized scientific legacy.[1]

Abstract

Kazunari K. Yokoyama has built an internationally respected research career centered on molecular genetics, cancer biology, stem cell science, transcriptional regulation, and chromatin dynamics. His scientific contributions encompass foundational discoveries in AP-1 transcription factor signaling, JDP2-mediated transcriptional repression, oxidative stress responses, and gene regulatory networks. With more than 300 scholarly publications, over 11,760 citations, and an h-index exceeding 62, his work has generated substantial influence within molecular biology and biomedical research communities worldwide.[1]

Keywords

Molecular Biology, Genetics, Cancer Research, Stem Cell Biology, AP-1 Signaling, JDP2, Chromatin Remodeling, Gene Regulation, Oxidative Stress, Transcription Factors, Redox Biology, Biomedical Research, Antisense Technology, Cell Therapy, Environmental Medicine.

Introduction

Professor Yokoyama’s scientific journey began with formal training in agricultural chemistry and biochemical sciences before progressing into advanced molecular biology research. Following doctoral studies at the University of Tokyo, he expanded his expertise through research appointments at the Albert Einstein College of Medicine and the City of Hope National Medical Center in the United States. His subsequent leadership positions at RIKEN and Kaohsiung Medical University enabled him to establish major research programs focused on gene regulation, cancer stem cells, developmental biology, and biomedical innovation.[2]

Research Profile

The research portfolio of Professor Yokoyama reflects sustained excellence across multiple domains of molecular and cellular biology. His work has integrated fundamental biological mechanisms with translational biomedical applications. Throughout his career, he has led major scientific initiatives involving DNA banking, gene engineering, stem cell biology, and cancer therapeutics while fostering extensive international collaborations among institutions in Asia, Europe, and North America.[2]

  • Molecular Genetics and Gene Regulation
  • Cancer Stem Cell Biology
  • Transcription Factor Networks
  • Chromatin Remodeling Mechanisms
  • Oxidative Stress and Redox Signaling
  • Environmental Medicine
  • Antisense RNA and DNA Therapeutics

Research Contributions

Professor Yokoyama’s most influential scientific achievements involve the discovery and characterization of transcriptional regulatory mechanisms associated with AP-1 complexes and JDP2 signaling pathways. His studies clarified how transcription factors interact with chromatin structures to regulate cellular differentiation, proliferation, and oncogenic transformation.[3]

  • Pioneering studies on AP-1 transcription factor biology.
  • Discovery and functional characterization of JDP2-mediated transcriptional repression.
  • Advances in chromatin remodeling and epigenetic regulation.
  • Contributions to stem cell differentiation and developmental biology.
  • Development of antisense nucleic acid therapeutic strategies.
  • Research linking oxidative stress pathways to cancer progression.
  • Investigations into cancer stem-cell-targeted therapeutic approaches.

Publications

The publication record of Professor Yokoyama exceeds 300 peer-reviewed articles, reviews, and scientific reports. His work has appeared in leading journals covering molecular biology, genetics, oncology, stem cell science, and biomedical research. Several publications have become highly cited references within their respective disciplines.[1]

  • AP-1 transcription factor signaling and cellular regulation.
  • JDP2-mediated transcriptional control mechanisms.
  • Stem cell differentiation and pluripotency studies.
  • Chromatin modification and epigenetic regulation.
  • Cancer stem cell biology and therapeutic innovation.

Research Impact

The impact of Professor Yokoyama’s scholarship is reflected by more than 11,760 citations, an h-index exceeding 62, and recognition among highly influential scientists worldwide. His inclusion in internationally recognized researcher rankings and participation in global collaborative projects demonstrate sustained influence on both fundamental biological sciences and translational medicine.[1]

  • 300+ peer-reviewed publications.
  • 11,760+ scholarly citations.
  • h-index above 62.
  • International collaborations across Asia, Europe, and North America.
  • Leadership roles in DNA banking and gene engineering initiatives.

Award Suitability

Professor Kazunari K. Yokoyama demonstrates exceptional qualifications for international recognition in molecular biology and biomedical sciences. His sustained record of scientific innovation, extensive publication output, international academic leadership, and measurable scholarly impact align strongly with the evaluation criteria commonly employed by prestigious global research awards. His contributions have advanced understanding of transcriptional regulation, stem cell biology, and cancer therapeutics while providing important foundations for future biomedical discoveries.[2]

Conclusion

Kazunari K. Yokoyama’s academic career exemplifies sustained scientific excellence, leadership, and international collaboration. Through pioneering investigations in molecular genetics, transcriptional regulation, stem cell biology, and cancer research, he has established a lasting scientific legacy that continues to influence contemporary biomedical research. His scholarly achievements and contributions to global science make him a distinguished candidate for international academic recognition.[1]

References

  1. Elsevier. (n.d.). Scopus Author Details: Kazunari K. Yokoyama, Author ID 7401877315. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=7401877315
  2. Yokoyama, K.K. Curriculum Vitae and Professional Academic Record.
    https://scholar.google.com/citations?user=3JIMA5EAAAAJ&hl=en
  3. Yokoyama, K.K. et al. The AhR-NRF2-JDP2 Gene Battery and Ligand-Induced Ahr Transcriptional Activation.

Prof. Tian-yun Wang | Genetics and Molecular Biology | Scientific Excellence Achievement Award

Published on by World Science Awards

Prof. Tian-yun Wang | Genetics and Molecular Biology | Scientific Excellence Achievement Award

Henan Medical University, China

Prof. Tianyun Wang is a renowned Professor in the Department of Biochemistry and Molecular Biology at Xinxiang Medical University, China, recognized for his pioneering contributions to molecular genetics and recombinant protein engineering. He holds a Ph.D. in Genetics from Zhengzhou University (2005), a Master’s degree in Biochemical Engineering from Shanghai University (2001), and a Bachelor’s degree in Biological Education from Qufu Normal University (1993). With over two decades of academic and research excellence, Prof. Wang has served as Professor and Deputy Director at Xinxiang Medical University since 2012, following earlier roles as Associate Professor and Lecturer. His professional expertise lies in cellular bioengineering, molecular genetics, and protein expression, particularly in advancing recombinant protein production in Chinese Hamster Ovary (CHO) cells—a cornerstone in modern biopharmaceutical development. Prof. Wang’s research interests include genetic regulation, molecular cloning, and the biotechnological enhancement of therapeutic protein yield and quality. His technical proficiency encompasses advanced cell culture systems, gene editing, molecular modeling, and bioinformatics analysis, reflecting a strong command of both experimental and computational tools. With 170 publications, 2,513 citations, and an h-index of 24, his scholarly output underscores his global influence and sustained scientific innovation. His honors include the Scientific Innovation Talent Award (2015), Outstanding Teacher Award (2012), and multiple provincial science and technology prizes, reflecting his excellence in both research and education. Prof. Wang has successfully led numerous nationally funded research projects, contributing significantly to China’s biotechnological advancement. His academic leadership, research acumen, and mentorship have shaped many young scientists in molecular life sciences. In conclusion, Prof. Tianyun Wang stands as a distinguished scholar whose visionary research and commitment to innovation continue to bridge molecular biology and industrial biotechnology, driving forward advancements in recombinant protein production and contributing meaningfully to global biomedical science.

Profiles: Scopus | ORCID

Featured Publications

  1. Han, Z., Han, X., Cheng, W., Geng, S., Li, W., Wang, T., & Wang, X. (2025). Application of transposon expression system in recombinant protein expression and gene therapy. Biochimie.

  2. Geng, S., Zou, Y., Bai, Z., Zhang, M., Wang, C., & Wang, T. (2025). Serum‐free medium for recombinant protein expression in insect cells. Biotechnology and Applied Biochemistry.

  3. Yuan, J., Geng, S., & Wang, T. (2025). Research progress fusion tags for recombinant protein production. Biotechnology and Applied Biochemistry.

  4. Wang, C., Guo, X., Wang, W., Li, J. X., & Wang, T. (2025). From cell clones to recombinant protein product heterogeneity in Chinese hamster ovary cell systems. International Journal of Molecular Sciences, 26(3), 1324.

  5. Fu, Y., Han, Z., Cheng, W., Niu, S., Wang, T., & Wang, X. (2024). Improvement strategies for transient gene expression in mammalian cells. Applied Microbiology and Biotechnology.

Prof. Tianyun Wang’s work significantly advances global biopharmaceutical innovation through cutting-edge research in recombinant protein engineering and molecular genetics. His contributions enhance the efficiency of therapeutic protein production, bridging scientific discovery with industrial biotechnology to improve healthcare and promote sustainable biomedical development worldwide.

Muhammad Farhat Ullah | Genetics and Molecular Biology | Best Researcher Award

Published on by World Science Awards

Assist. Prof. Dr. Muhammad Farhat Ullah | Genetics and Molecular Biology | Best Researcher Award

University of Sialkot | Pakistan

Assist. Prof. Dr. Muhammad Farhat Ullah is a highly accomplished researcher and academic specializing in bioinformatics, molecular biology, forensic genomics, and population genetics. With over eight years of teaching and research experience, he has developed a reputation as an innovative scientist and dedicated mentor. He earned his Ph.D. in Bioinformatics from Quaid-i-Azam University Islamabad, where his research focused on genetic variability, population genomics, and computational biology. Currently serving as an Assistant Professor at the University of Sialkot (USKT), he combines advanced computational techniques with experimental biology to solve pressing biological and forensic problems. Dr. Ullah has made significant contributions to scientific literature with more than twenty peer-reviewed publications in prestigious journals indexed in Scopus and Web of Science. His works span diverse areas, including Y-STR mutation analysis, nanotechnology applications in biomedical sciences, population structure studies, and computational approaches to drug discovery. International collaborations with research groups in Italy, China, and the UAE highlight his global research presence. In addition to his scientific contributions, Dr. Ullah plays an active role in departmental leadership as Secretary of multiple academic committees and serves as a mentor for graduate and undergraduate students, promoting research excellence and innovation.

Professional Profile

Education

Assist. Prof. Dr. Muhammad Farhat Ullah academic journey reflects a consistent pursuit of excellence and interdisciplinary expertise. He began his higher education with a Bachelor of Science degree in Biotechnology from Gomal University, Dera Ismail Khan, Pakistan. During his undergraduate studies, he developed a strong foundation in molecular biology, genetics, and laboratory research techniques. He then pursued his Master of Science in Biotechnology at the International Islamic University Islamabad, where his thesis work focused on rationalization of pharmacotherapy in infectious diseases, giving him exposure to molecular diagnostics and applied biotechnology. Building upon this, he advanced to doctoral studies at Quaid-i-Azam University Islamabad, one of Pakistan’s leading research institutions. He completed his Ph.D. in Bioinformatics, with a dissertation centered on population genetics, mutational analysis of rapidly mutating Y-STRs, and computational biology approaches to genomic studies. His doctoral research combined statistical modeling, bioinformatics tools, and molecular analysis to address population-level genetic variations with forensic and biomedical implications. Throughout his academic career, Dr. Ullah has consistently demonstrated interdisciplinary expertise, blending wet-lab techniques with computational genomics. His educational achievements reflect a strong progression from biotechnology fundamentals to advanced computational bioinformatics, positioning him as a well-rounded scholar in life sciences.

Professional Experience

Assist. Prof. Dr. Muhammad Farhat Ullah currently serves as an Assistant Professor in the Department of Biological Sciences at the University of Sialkot, Pakistan. In this role, he teaches undergraduate and graduate courses in bioinformatics, molecular biology, and biotechnology, while supervising multiple MS and BS research theses. His teaching portfolio includes advanced bioinformatics, industrial biotechnology, biosafety, recombinant DNA technology, synthetic biology, and computational biology. Prior to his current role, Dr. Ullah worked as a Research Assistant and committee member at Quaid-i-Azam University Islamabad, where he gained hands-on experience with DNA extraction, PCR, gel electrophoresis, protein modeling, and next-generation sequencing analysis. He has also collaborated with international institutions on population genetics projects, including the Sapienza University of Rome in Italy, research centers in China, and police forensic units in Dubai. Beyond teaching and research, he holds leadership roles as Secretary of the Board of Studies, Curriculum Review Committee, and Industrial Advisory Board at USKT. His professional journey demonstrates a balance of academic instruction, research innovation, and administrative leadership. Through active mentorship, he is contributing to the development of the next generation of scientists while continuing to expand his global research collaborations.

Research Interests

Assist. Prof. Dr. Muhammad Farhat Ullah’s research interests are broad yet interconnected, reflecting his interdisciplinary training in biotechnology and bioinformatics. His primary focus lies in forensic genomics, where he investigates rapidly mutating Y-STRs and their applications in population genetics and forensic casework. He has contributed to understanding genetic diversity in Pakistani populations and collaborated with international groups to study Kohistani and Gilgiti populations, enhancing knowledge of South Asian genetic history. In addition, he explores bioinformatics-driven approaches for drug discovery and development, employing computational tools to model proteins, analyze mutations, and identify molecular targets. His work also extends to nanotechnology, where he evaluates nanoparticles and nanocomposites for biomedical and environmental applications, such as photocatalysis and drug delivery. Dr. Ullah has also been actively engaged in pandemic-related research, including the use of CRISPR/Cas9 technology in COVID-19 treatment strategies. He is equally passionate about population genomics, mitochondrial genomics, and exome sequencing, integrating advanced statistical methods with molecular data. His multidisciplinary research interests demonstrate his commitment to applying computational biology in solving real-world problems in healthcare, forensic science, and environmental sustainability. This fusion of molecular experimentation and computational analysis positions him at the cutting edge of modern life sciences research.

Research Skills

Assist. Prof. Dr. Muhammad Farhat Ullah possesses a diverse skill set that integrates both laboratory-based molecular biology techniques and advanced computational bioinformatics tools. His experimental expertise includes DNA extraction, PCR amplification, gel electrophoresis, polyacrylamide gel electrophoresis, Sanger sequencing, and capillary electrophoresis using Applied Biosystems Genetic Analyzers (310 and 3100). He is skilled in STR biomarker analysis, including Y-STRs and rapidly mutating STRs, which are widely applied in forensic genetics and population studies. On the computational side, he has extensive experience with whole exome sequencing analysis, protein modeling, primer designing, and in-silico mutational analysis. He is proficient in statistical data analysis using MATLAB (R2022b) and multiple bioinformatics software platforms for gene scanning, genotyping, and protein structure evaluations. His technical expertise further extends to nanotechnology characterization techniques, computational drug discovery, and modeling of genetic variations. In addition, Dr. Ullah has strong skills in teaching and mentoring, supervising student projects involving computational genomics, SNP analysis, and phylogenetic studies. His ability to bridge wet-lab and dry-lab skills makes him a versatile scientist, capable of handling diverse research projects. By combining hands-on experimental knowledge with computational proficiency, Dr. Ullah contributes to advancing molecular biology, forensic science, and biomedical applications.

Awards and Honors

Assist. Prof. Dr. Muhammad Farhat Ullah has received recognition for his academic achievements, research contributions, and leadership roles. During his Ph.D., he was awarded the prestigious IRSIP fellowship by the Higher Education Commission (HEC) of Pakistan, which enabled him to undertake an international research internship at the Sapienza University of Rome, Italy. This fellowship provided him with exposure to cutting-edge genetic research methodologies and allowed him to collaborate with world-renowned population geneticists. At the University of Sialkot, he has been entrusted with significant academic leadership responsibilities, including serving as Secretary of the Board of Studies, Curriculum Review Committee, and Industrial Advisory Board within the Department of Biological Sciences. His professional achievements also include active participation in international collaborations with institutions in China, Dubai, and Italy, contributing to projects on population genetics, forensic applications of Y-STRs, and mitochondrial genomics. In addition to formal recognition, he has built a strong publication record in high-impact journals, which reflects his growing influence in the scientific community. These achievements, coupled with his dedication to student mentorship and research advancement, demonstrate his standing as an emerging leader in bioinformatics and molecular genetics at both national and international levels.

Publication Top Notes

  • Population and mutational assessment of novel repeats in 13RM Y-STRs in unrelated males born in Gilgit, Pakistan — 2022

  • Novel heterozygous frameshift mutation in distal-less homeobox 5 underlies isolated split hand/foot malformation type 1 — 2016

  • Evaluation of rapidly mutating Y-STRs in Pakistani population — 2019

  • A review of COVID-19: Treatment strategies and CRISPR/Cas9 gene editing technology approaches to the coronavirus disease — 2021

  • Biosynthesis of silver nanoparticles from novel Bischofia javanica plant loaded chitosan hydrogel: as antimicrobial and wound healing agent — 2022

  • Structural Evaluation and Conformational Dynamics of ZNF141T474I Mutation Provoking Postaxial Polydactyly Type A — 2022

  • RM-plex kit to analyze 130 father-son pairs from Gilgit Baltistan region of Pakistan at 13 RM Y-STR loci, producing unique mutation data and merging it with previously reported mutation data.

Conclusion

In conclusion, Assist. Prof. Dr. Muhammad Farhat Ullah exemplifies the qualities of an outstanding researcher, academic leader, and mentor. His educational foundation in biotechnology and bioinformatics, coupled with his extensive research in forensic genomics, computational biology, and nanotechnology, positions him as a versatile and impactful scholar. With more than twenty international publications, several collaborative projects, and active involvement in student supervision, he has significantly contributed to advancing knowledge in population genetics, forensic casework, and biomedical applications. His IRSIP fellowship experience in Italy and collaborations with global institutions reflect his ability to integrate international expertise into local research contexts, thereby strengthening Pakistan’s presence in the global scientific arena. Dr. Ullah’s technical proficiency, innovative research approaches, and dedication to teaching make him a role model for aspiring scientists. Moving forward, his commitment to expanding Q1 publications, engaging in editorial responsibilities, and pursuing broader global collaborations will further enhance his academic footprint. With proven leadership at his institution and a growing international reputation, Dr. Ullah has the potential to become a leading figure in bioinformatics and molecular sciences. His contributions to science and education make him a deserving candidate for recognition at the international level.

Veronika Bouskova | Molecular Biology | Best Researcher Award

Published on by World Science Awards

Dr. Veronika Bouskova | Molecular Biology | Best Researcher Award

Young scientist from Biomedical Centre in Pilsen, Czech Republic.

Dr. Veronika Boušková (née Brynychová) is a distinguished Czech researcher in the field of molecular biology and pharmacogenomics, with a particular focus on breast cancer biology and genetic variability. Her career combines academic research, laboratory-based investigation, and mentoring of young scientists. With a Ph.D. from the Third Faculty of Medicine at Charles University and over a decade of experience at premier research institutions like the Biomedical Center of the Faculty of Medicine in Pilsen and the National Institute of Public Health in Prague, she has established herself as a leading expert in transcriptomic analysis, caspase signaling, and the clinical implications of genetic variants in cancer prognosis and treatment. Dr. Boušková has authored or co-authored numerous articles published in high-impact journals and holds an impressive h-index of 13. Her research is notable for its integrative approach, combining molecular, cellular, and genetic data to better understand cancer progression and therapy resistance. She is also actively involved in academic education and mentoring, guiding the next generation of scientists. Her ability to conduct interdisciplinary research and her contributions to clinical and translational oncology make her a strong candidate for recognition through research awards.

Professional Profile

Education

Dr. Boušková has pursued a rigorous and interdisciplinary educational path rooted in biological sciences. She earned her Bachelor’s degree in Biology from the Faculty of Science at Charles University in 2008, followed by a Master’s degree in Biology, which she completed in 2010 through a collaborative program involving the Department of Anthropology and Human Genetics and the Institute of Archaeology at the Academy of Sciences. Her education culminated in a Ph.D. in Molecular and Cell Biology, Genetics, and Virology from the Third Faculty of Medicine, Charles University, which she pursued from 2010 to 2018. Her doctoral studies provided her with a comprehensive understanding of molecular and cellular mechanisms involved in human diseases, with a particular emphasis on cancer genetics and apoptosis. This strong educational foundation, grounded in both human genetics and molecular medicine, has enabled her to bridge basic scientific research with clinical applications. Additionally, Dr. Boušková’s involvement in interdisciplinary and international study programs reflects her commitment to continuous academic and professional growth, and has enriched her scientific perspective with cultural and methodological diversity.

Professional Experience

Dr. Boušková’s professional journey reflects her long-standing commitment to biomedical research and her evolving expertise in oncology-related molecular genetics. Since 2013, she has served as a Junior Researcher at the Biomedical Center, Faculty of Medicine in Pilsen, Charles University, where she works in the Laboratory of Pharmacogenomics. Simultaneously, she has maintained a research position at the National Institute of Public Health in Prague since 2010. Her work across both institutions focuses on investigating genetic variability, apoptosis-related genes, and microRNA expression in cancer patients, especially those with breast carcinoma. Between August 2019 and January 2022, she was on maternity leave, after which she resumed her scientific endeavors. Dr. Boušková has also been actively involved in teaching since 2015, conducting practical courses in biochemical laboratory techniques at the Faculty of Science, Charles University. She has mentored and consulted graduate students, contributing to their academic development and research projects. Her dual roles in research and education reflect a well-rounded professional profile combining laboratory excellence, mentorship, and scientific publication. Her sustained engagement in public health-oriented molecular research illustrates her commitment to improving healthcare outcomes through advanced biomedical science.

Research Interests

Dr. Veronika Boušková’s research interests center on the molecular and genetic mechanisms underlying cancer development and progression, with a particular emphasis on breast carcinoma. Her work delves into the regulation of apoptosis, the role of caspases and their isoforms, transcriptomic alterations, and microRNA expression profiles in tumor cells. She is especially interested in the pharmacogenomic implications of genetic variability, including single nucleotide polymorphisms and gene expression regulation that influence cancer prognosis and therapy response. Her integrative research also covers transcript and protein expression of genes involved in cell cycle control, epithelial-mesenchymal transition, and multidrug resistance. Additionally, Dr. Boušková has explored the impact of epigenetic modifications and miRNA-mediated gene regulation in breast cancer subtypes. Her interdisciplinary approach, combining molecular biology, genetics, pharmacology, and bioinformatics, contributes to identifying potential therapeutic targets and predictive biomarkers. She is committed to translational research, bridging laboratory findings with clinical practice to enhance personalized medicine strategies in oncology. Her recent publications reflect ongoing investigations into breast cancer microenvironment signaling, resistance mechanisms, and molecular diagnostics, demonstrating her ability to stay at the forefront of contemporary cancer research.

Research Skills

Dr. Boušková possesses a broad and advanced skill set in molecular biology and cancer genomics, honed over years of hands-on laboratory experience. Her research skills include gene expression analysis using RT-qPCR, microarray profiling, RNA sequencing, and high-resolution melting analysis. She is proficient in DNA/RNA extraction, reverse transcription, genotyping, and bioinformatics tools for analyzing transcriptomic and genomic datasets. Dr. Boušková is also skilled in cell culture techniques, protein expression studies, and functional assays relevant to apoptosis and cell signaling pathways. Her expertise extends to microRNA analysis and the use of pathway prediction software for understanding gene regulation networks. Moreover, she is well-versed in data interpretation, manuscript preparation, and collaborative research processes, contributing meaningfully to multidisciplinary teams. Her methodological rigor is evident from her contributions to over 25 peer-reviewed publications, many in high-impact journals. Additionally, she has experience in research project planning, laboratory management, and supervising student projects. Her continuous engagement with modern experimental technologies and analytical software ensures her research remains current and impactful. Her technical proficiency, analytical mindset, and collaborative approach make her a valuable contributor to complex research initiatives.

Awards and Honors

Dr. Boušková’s career includes several academic and research achievements, reflecting her dedication to high-quality scientific work. Notably, she was the recipient of a research grant from the Charles University Grant Agency (GAUK) from 2013 to 2015 for her project on the significance of apoptotic caspases and their splice variants in breast carcinoma. The project was successfully evaluated with all objectives fulfilled, highlighting her ability to manage and complete competitive research funding initiatives. Furthermore, she was awarded an internship opportunity in May 2014 at the National Research Institute of Chinese Medicine, under Dr. Yune-Fang Ueng’s laboratory, indicating her proactive pursuit of international research exposure. While there are no listings of specific awards such as national medals or society fellowships, her consistent record of high-impact publications, a strong citation index, and an h-index of 13 represent substantial academic honors in themselves. Her mentoring of graduate students and teaching contributions also reflect recognition within academic circles. Dr. Boušková’s recognition comes primarily through peer-reviewed scientific contributions and successful grant acquisitions, both of which underscore her qualifications for further accolades like the Best Researcher Award.

Conclusion

Dr. Veronika Boušková exemplifies the qualities of a top-tier biomedical researcher with a career marked by academic excellence, impactful research, and active mentorship. Her scientific focus on breast cancer genomics, microRNA regulation, and pharmacogenomics addresses some of the most pressing challenges in oncology today. With a strong publication record, an h-index of 13, and sustained research activity at reputable institutions, she has demonstrated not only productivity but also relevance and innovation in her field. Her interdisciplinary education and global research exposure further enhance her ability to navigate complex scientific questions. While expanding her international collaborations and taking on larger leadership roles in research consortia could elevate her profile further, her current contributions already reflect a researcher of significant merit and potential. Her dual commitment to research and education positions her as an influential figure within both academic and clinical research landscapes. In light of her qualifications, Dr. Boušková is highly deserving of recognition through awards such as the Best Researcher Award, which would not only honor her achievements but also support her future research endeavors aimed at improving cancer diagnosis and treatment.

Publications Top Notes

  1. Integrative analysis of mRNA and miRNA expression profiles and somatic variants in oxysterol signaling in early-stage luminal breast cancer
    Authors: Petr Holý, Veronika Brynychová, Karolína Šeborová, Vojtěch Haničinec, Renata Koževnikovová, Markéta Trnková, David Vrána, Jiří Gatěk, Kateřina Kopečková, Marcela Mrhalová, Pavel Souček, et al.
    Journal: Molecular Oncology
    Year: 2023
    Citations: 3
  2. Single Nucleotide Variants in KIF14 Gene May Have Prognostic Value in Breast Cancer
    Authors: Ivona Krus, Veronika Brynychová, Viktor Hlaváč, Radka Václavíková, Maria Kováčová, Renata Koževnikovová, Kateřina Kopečková, Jannis Tornikidis, David Vrána, Jiří Gatěk, Pavel Souček
    Journal: Molecular Diagnosis and Therapy
    Year: 2022
    Citations: 2

 

Nazneen Naher Islam | Molecular Biology | Best Researcher Award

Published on by World Science Awards

Prof. Dr. Nazneen Naher Islam | Molecular Biology | Best Researcher Award

Professor from Department of Genetic Engineering and Biotechnology, University of Chittagong, Bangladesh

Prof. Dr. Nazneen Naher Islam is an accomplished researcher and academic with a distinguished career in microbial genetics, genetic disorders, and molecular pathogenesis. She currently serves as Professor and Chairman of the Department of Genetic Engineering and Biotechnology at the University of Chittagong, Bangladesh. Her academic journey is marked by a strong international background, having completed her Ph.D. in Microbial Protein Engineering at Osaka City University, Japan. Dr. Islam’s work focuses extensively on genetic mutations, the molecular basis of diseases, microbial metabolite screening, and antibiotic resistance, which are highly relevant to public health concerns in Bangladesh and beyond. She has published numerous research articles in national and international journals and has contributed significantly to conference proceedings. Her leadership extends beyond research as she has successfully supervised 35 graduate students and actively teaches advanced courses in genetics and biotechnology. Dr. Islam has received several prestigious awards and scholarships throughout her academic career, reflecting her dedication and scientific excellence. Her professional affiliations with international and national microbiology and biotechnology societies further illustrate her active role in the scientific community. Prof. Dr. Nazneen Naher Islam’s academic contributions, research leadership, and dedication to mentoring the next generation of scientists make her a standout figure in her field.

Professional Profile

Education

Prof. Dr. Nazneen Naher Islam’s educational background showcases her progression through rigorous scientific training and specialization. She earned her Ph.D. in Microbial Protein Engineering from Osaka City University, Japan, between 2004 and 2008. Her doctoral research focused on the synthesis and degradation of acyl peptides by ATP and CoA-independent N-myristoyltransferase enzymes derived from Pseudomonas aeruginosa and Escherichia coli. This work laid the foundation for her later contributions to microbial genetics and biotechnology. Prior to her doctoral studies, Dr. Islam completed both her Bachelor of Science and Master of Science degrees in Botany at the University of Chittagong, Bangladesh. Her master’s research concentrated on microbial enzymes, where she graduated with First Class distinction. She completed her Higher Secondary Certificate and Secondary School Certificate from the Board of Intermediate and Secondary Education, Comilla, securing First Division results in both examinations. Her educational journey not only reflects academic excellence but also demonstrates her early commitment to the biological sciences. The blend of local and international education has uniquely positioned her to lead complex research projects that address both national health priorities and global scientific challenges.

Professional Experience

Prof. Dr. Nazneen Naher Islam has built an impressive professional career as a professor, researcher, and leader at the University of Chittagong, where she currently serves as Professor and Chairman of the Department of Genetic Engineering and Biotechnology. Over the years, she has gained extensive experience in leading multidisciplinary research teams and supervising graduate-level research. Her professional journey includes teaching specialized subjects such as microbial genetics, cytogenetics, pharmaceutical biotechnology, recombinant DNA technology, and industrial biotechnology. In addition to her academic roles, Dr. Islam has been involved in significant institutional responsibilities, including past service as a house tutor and member of the Teachers Association at Chittagong University. She has also worked as a reviewer for several national and international journals, ensuring the quality and rigor of scientific publications. Her research portfolio features numerous externally funded projects, particularly from the University Grants Commission of Bangladesh, where she has led studies on genetic mutations, microbial resistance, and public health microbiology. Throughout her career, she has demonstrated a strong commitment to advancing the fields of microbial genetics and public health while nurturing the academic growth of her students and contributing actively to the scientific community.

Research Interest

Prof. Dr. Nazneen Naher Islam’s research interests are deeply rooted in microbial genetics, genetic diseases, and the molecular mechanisms of disease development. She focuses on the prevalence and mutation spectrum of genetic disorders within the Bangladeshi population, including studies on beta-thalassemia and other inherited diseases. Dr. Islam is also passionate about exploring the molecular pathogenesis and genomics of genetic diseases, aiming to uncover the biological underpinnings that can lead to improved diagnostic and therapeutic strategies. Another significant area of her research involves the screening, molecular characterization, and industrial application of microbial secondary metabolites, which hold potential in the pharmaceutical and biotechnological industries. Her work also addresses pressing public health issues, such as antibiotic resistance, microbial contamination in food, and transmission of drug-resistant pathogens. She is particularly interested in the application of molecular biology techniques, such as PCR-based diagnostics, in improving disease detection and management. Dr. Islam’s research is both applied and translational, with a focus on generating solutions that are locally relevant and globally significant. Her wide-ranging interests enable her to contribute to the intersection of genetics, microbiology, and public health, making her research impactful on both scientific and societal levels.

Research Skills

Prof. Dr. Nazneen Naher Islam possesses a robust set of research skills that position her as a leading scientist in the fields of microbial genetics and biotechnology. She is highly proficient in molecular biology techniques, including PCR, RT-PCR, plasmid profiling, gene mutation analysis, and molecular characterization of microbes. Her expertise extends to the purification and biochemical characterization of enzymes, particularly microbial enzymes with potential industrial applications. Dr. Islam is also skilled in antimicrobial susceptibility testing, which is essential for monitoring drug resistance patterns. Her ability to conduct metagenomic studies and comparative analyses of gut microbiota further enhances her multidisciplinary research capabilities. She is well-versed in public health microbiology, particularly in the detection and molecular typing of foodborne and waterborne pathogens such as Salmonella typhi, Staphylococcus aureus, and Vibrio cholerae. Additionally, Dr. Islam’s experience in supervising graduate students has refined her project management, experimental design, and scientific communication skills. Her involvement in collaborative and independently funded research projects demonstrates her capacity for grant writing, research planning, and data analysis. Altogether, her comprehensive research skill set supports her ability to address complex scientific questions and contribute meaningfully to advancements in microbial and genetic research.

Awards and Honors

Prof. Dr. Nazneen Naher Islam has been the recipient of several prestigious awards and honors throughout her academic and research career, reflecting her scientific excellence and leadership. She was awarded the National Scholarship for Foreign Students by Osaka City University in 2008, which recognized her outstanding academic performance and research contributions during her Ph.D. studies. Between 2004 and 2007, she also received the competitive Nishimura Scholarship while pursuing her doctoral degree in Japan. Earlier in her career, she was awarded the National Science and Technology Fellowship in Bangladesh during 1996-1997, which supported her postgraduate research. Additionally, Dr. Islam has secured multiple research grants from the University Grants Commission (UGC) of Bangladesh, including funding for significant projects related to genetic mutation analysis and the detection of foodborne pathogens. Her project on the mutation analysis of the HBB gene in beta-thalassemic patients and the detection of Staphylococcus aureus in frozen chicken rinse are examples of her impactful, grant-funded research. These honors and recognitions underline her dedication to advancing genetic and microbial research and affirm her position as a respected leader in the academic and scientific communities.

Conclusion

Prof. Dr. Nazneen Naher Islam is a distinguished researcher, educator, and leader whose contributions to microbial genetics, public health microbiology, and genetic disease studies have had significant impact both within Bangladesh and in the broader scientific community. Her multidisciplinary research integrates cutting-edge molecular biology techniques with practical applications in public health and the food industry. Throughout her career, she has demonstrated remarkable dedication to education by supervising a large number of graduate students and by delivering high-quality teaching in genetic engineering and biotechnology. Her professional affiliations, international collaborations, and consistent involvement in research grants and scholarly publishing reflect her commitment to academic excellence and community service. While further engagement in international conferences and collaborations could amplify her global presence, Dr. Islam’s track record clearly positions her as a leading researcher in her field. Her ability to address critical health issues through research, coupled with her passion for student mentorship and institutional leadership, make her a highly deserving candidate for prestigious recognitions such as the Best Researcher Award. Her continued work is expected to contribute substantially to the advancement of biotechnology, public health, and genetic research in Bangladesh and beyond.

Publications Top Notes

  1. Title: Antibacterial Activity of Terminalia Chebula and Erythrina Variegata Extracts against Pathogen Causing Respiratory Tract Infection
    Authors: Chandrika Das, Dil Umme Salma Chowdhury, Md. Abdul Mannan, Nazneen Naher Islam
    Year: 2021

  2. Title: Plasmid profiling of multiple antibiotic-resistant Pseudomonas aeruginosa isolated from soil of the industrial area in Chittagong, Bangladesh
    Authors: Asma Talukder, Md. Mijanur Rahman, Mohammed Mehadi Hassan Chowdhury, Tanha Amina Mobashshera, Nazneen Naher Islam
    Year: 2021

  3. Title: Assessment of molecular and clinical characteristics in blood transfusion dependent HbE/β-thalassemia patients
    Authors: Nazneen Naher Islam, Mohabbat Hossain, Shuvo Chandra Das, Sabrina Alam Seuti, Razia Sultana, Mahmood A. Chowdhury
    Year: 2020

  4. Title: Vibrio cholerae transmits through water among the household contacts of cholera patients in cholera endemic coastal villages of Bangladesh, 2015-2016 (CHoB17 Trial)
    Authors: Zillur Rahman, Md. Anisur Rahman, Mahamud-ur-Rashid, Shirajum Monira, Fatema-Tuz Johura, Munshi Mustafiz, Sazzadul I. Bhuyian, Fatema Zohura, Tahmina Parvin, Khaled Hasan, K. M. Saif-Ur-Rahman, Nazneen Naher Islam, David A. Sack, Christine M. George, Munirul Alam
    Year: 2018

  5. Title: Bacteriological and ecfX-gene specific PCR based identification of Pseudomonas aeruginosa isolated from Chittagong industrial area and characterization of its extracellular amylase
    Authors: Asma Talukder, Tanha Amina Mobashshera, Istiaq Uddin Ahmed, Nazneen Naher Islam
    Year: 2018

  6. Title: Identification and Screening of Lactobacillus spp. from Selective Regional Yoghurts for Probiotic and Interference with Pathogenic Bacterial Growth
    Authors: Kamrun Naher Islam, Touaha Akbar, Fahmida Akther, Nazneen Naher Islam
    Year: 2016

  7. Title: Detection of Staphylococcus aureus in Frozen Chicken Rinse through Bacteriological and Nuc Gene specific PCR Methods and Drug resistance Patterns in Southern Chittagong, Bangladesh
    Authors: Nazneen Naher Islam, Mahmuda Akter, Zinat Farzana, Abdul Jabber Bin Kader, Inkeyas Uddin, AMAM Zonaed Siddiki, K M Kamaruddin
    Year: 2014

Fatma Cavus Yonar | Molecular Biology | Best Researcher Award

Published on by World Science Awards

Assist. Prof. Dr. Fatma Cavus Yonar | Molecular Biology | Best Researcher Award

Assistant Professor PhD from Istanbul University-Cerrahpasa Institute of Forensic Sciences and Legal Medicine Department of Science, Turkey

Dr. Fatma Çavuş Yonar is a distinguished academic and researcher in the field of forensic sciences with a specialization in analytical chemistry, forensic genetics, and toxicology. Currently serving as a Dr. Lecturer at the Istanbul University-Cerrahpaşa Institute of Forensic Sciences, she brings over a decade of experience in forensic research and education. Her scholarly contributions include extensive work on psychoactive substances, forensic genetics, and crime scene investigation methodologies. She is actively involved in scientific publishing, holding editorial board memberships for three international journals. Her work emphasizes interdisciplinary research, integrating nanotechnology, molecular biology, and advanced chromatography techniques. Dr. Yonar has published numerous book chapters and has contributed to foundational forensic science literature. Her dedication to scientific rigor and innovation makes her a strong candidate for the Best Researcher Award. She has played a critical role in training the next generation of forensic scientists while pushing the boundaries of conventional forensic analysis. Her consistent scholarly output and leadership in forensic science education and research are indicative of her significant contributions to the academic and scientific communities.

Professional Profile

Education

Dr. Fatma Çavuş Yonar’s academic journey reflects her deep commitment to forensic sciences and interdisciplinary learning. She began her higher education in the Department of Biology Education at Hacettepe University, graduating in 2009. She then pursued her Master of Science degree in Forensic Sciences at Istanbul University, completing her thesis on the simultaneous determination of fentanyl and norfentanil using LC-MS/MS techniques in 2012. Her doctoral studies were conducted at Istanbul University-Cerrahpaşa Institute of Forensic Sciences, where she obtained her PhD in 2018 with a dissertation investigating molecular transformations in pen inks under various environmental conditions. Dr. Yonar’s academic trajectory showcases a clear progression from foundational science education to highly specialized forensic research. Her educational background has provided her with the necessary skills to address complex analytical problems in forensic science, with a particular emphasis on toxicology, molecular biology, and analytical chemistry. Her interdisciplinary expertise is evident in her research and teaching activities and aligns well with the evolving demands of modern forensic investigation.

Professional Experience

Dr. Fatma Çavuş Yonar has accumulated extensive experience in academia and research through her long-standing affiliation with Istanbul University. Her professional career began in 2011 as a Research Assistant at the Istanbul University Institute of Forensic Sciences. Over the next seven years, she actively contributed to research, publications, and laboratory training for postgraduate students. In 2020, she was appointed as a Dr. Lecturer at Istanbul University-Cerrahpaşa Institute of Forensic Sciences, where she currently teaches and supervises research in the Department of Science. Her responsibilities include curriculum development, guiding thesis projects, and collaborating on interdepartmental research initiatives. Dr. Yonar also serves on editorial boards for multiple forensic science journals, reflecting her standing in the academic community. Her practical experience extends to forensic genetics, toxicology, and the analysis of psychoactive substances. She has co-authored many influential book chapters and has been involved in numerous collaborative research projects. Her dual role as an educator and active researcher makes her a vital asset to the academic and scientific communities.

Research Interests

Dr. Fatma Çavuş Yonar’s research interests span a broad spectrum of forensic science disciplines, particularly forensic toxicology, analytical chemistry, forensic genetics, and crime scene investigation. She is especially focused on the molecular and chemical analysis of psychoactive substances and forensic trace evidence, such as ink and biological material. Her doctoral research explored the stability and transformation of ink molecules under various environmental conditions, demonstrating her interest in both chemical characterization and environmental influences on forensic samples. She is also actively engaged in developing analytical techniques using nanotechnology and molecular diagnostics, with a focus on applications in forensic genetics and toxicology. Another significant area of her research is the analysis of designer drugs and new-generation psychoactive substances using chromatographic techniques. Her interdisciplinary approach allows her to bridge the gap between classical forensic methodologies and modern molecular technologies. Dr. Yonar’s work contributes to improved methodologies for evidence evaluation and supports advancements in forensic identification, substance detection, and expert testimony.

Research Skills

Dr. Fatma Çavuş Yonar possesses a robust set of research skills that are essential for cutting-edge forensic investigations. She is proficient in advanced analytical techniques, including liquid chromatography-tandem mass spectrometry (LC-MS/MS), gas chromatography, and spectroscopic methods. Her expertise extends to molecular biology tools, forensic DNA analysis, and epigenetics. She has practical experience in RNA-based identification and the forensic examination of biological and digital evidence. Her skills are further demonstrated through her contributions to interdisciplinary book chapters and her research on nanoscience applications in forensic genetics. Dr. Yonar is also experienced in handling statistical methods for evaluating forensic genetic data, which enhances the reliability of her research outcomes. She has conducted extensive research on psychoactive substances and their legal implications, combining chemical analysis with forensic context. Her research skills are not only technical but also conceptual, as she effectively integrates science with forensic interpretation, making her research outputs both academically rigorous and practically applicable.

Awards and Honors

While specific awards and honors were not explicitly listed in the profile provided, Dr. Fatma Çavuş Yonar’s professional achievements and responsibilities are indicative of significant peer recognition. Her appointment as an editorial board member for three international journals in 2024 highlights her leadership and expertise in the field. Editorial roles are typically reserved for well-established researchers who have demonstrated consistent contributions and hold influence in their disciplines. In addition, her longstanding academic role at Istanbul University-Cerrahpaşa, along with her published chapters in internationally recognized forensic science books, reflects the high regard in which she is held by her peers. These professional appointments and scholarly contributions collectively suggest a commendable level of recognition and respect in the scientific community, underscoring her qualification for prestigious awards such as the Best Researcher Award.

Conclusion

Dr. Fatma Çavuş Yonar is a highly qualified candidate for the Best Researcher Award, demonstrating a sustained commitment to forensic science through education, research, and academic service. Her work integrates analytical chemistry, molecular biology, and forensic toxicology, enabling her to contribute valuable advancements to both theory and practice. With a strong foundation in research methodology, she has produced high-impact scholarly work, participated in interdisciplinary collaborations, and mentored upcoming forensic scientists. Her editorial responsibilities in international journals and contributions to forensic literature further validate her leadership in the field. While a more detailed list of honors could further strengthen her profile, her current accomplishments already reflect a well-established and impactful career. Dr. Yonar exemplifies the qualities of an innovative and dedicated researcher, and her recognition with this award would acknowledge her significant role in advancing forensic science and promoting academic excellence.

Publications Top Notes

  • Title: The other side of the paper as the evidence: impacts of fingermark development reagents on fingermark development and cocaine amount in cocaine-impregnated paper
    Journal: Forensic Science, Medicine and Pathology
    Date: 2024-10-17
    DOI: 10.1007/s12024-024-00897-2
    Contributors: Yakup Gulekci, Fatma Cavus Yonar, Pınar Efeoglu Ozseker, İsmail Ethem Gören, Nebile Daglioglu

  • Title: Short-cut route validated for monitoring fentanyl and its metabolite in urine using LC–MS/MS, in a wide concentration range
    Journal: Future Journal of Pharmaceutical Sciences
    Date: 2024-07-04
    DOI: 10.1186/s43094-024-00657-7
    Contributors: Fatma Cavus Yonar, Beril Anılanmert, Munevver Acikkol

  • Title: The effect of fingerprint enhancement methods applied on adhesive surfaces on DNA recovery: a preliminary study
    Journal: Journal of Scientific Reports-A
    Date: 2024-03-31
    DOI: 10.59313/jsr-a.1375939
    Contributors: Fatma Cavus Yonar, Yakup Gülekçi

  • Title: False Positives in Luminal Testing
    Journal: Black Sea Journal of Engineering and Science
    Date: 2024-01-15
    DOI: 10.34248/bsengineering.1391613
    Contributors: Yakup GÜLEKÇİ, Fatma CAVUS YONAR

  • Title: Speedy Gonzales analysis method in one drop of beverage, for crimes committed with drugs from three different groups
    Journal: Analytical Sciences
    Date: 2023-06
    DOI: 10.1007/s44211-023-00282-z
    Contributors: Beril Anilanmert, Fatma Cavus Yonar

  • Title: Comparison of methods to develop fingerprints on papers impregnated with AB‐PINACA and AB‐FUBINACA
    Journal: Journal of Forensic Sciences
    Date: 2022-03
    DOI: 10.1111/1556-4029.14926
    Contributors: Yakup Gulekci, Pınar Efeoglu Ozseker, Fatma Cavus Yonar, Nebile Daglioglu

  • Title: DNA profiling for forensic identification in Bulgarian Turks
    Journal: Medicine Science | International Medical Journal
    Date: 2021
    DOI: 10.5455/medscience.2020.12.254
    Contributor: Fatma Cavus Yonar

  • Title: Who touched the document?: A new overall strategy for collection and identification of DNA from the questioned documents as a supportive evidence
    Journal: ELECTROPHORESIS
    Date: 2021-10
    DOI: 10.1002/elps.202100192
    Contributor: Fatma Cavus Yonar

  • Title: Assessment of 13 Single Nucleotide Polymorphisms Loci for Identification in Forensic Sciences for Turkish Population
    Journal: International Journal of Biology and Chemistry
    Date: 2021-06
    DOI: 10.26577/ijbch.2021.v14.i1.05
    Contributor: Fatma Cavus Yonar

  • Title: CONFORMITY ASSESSMENT OF TEMPERATURE MEASURING DEVICES USED IN FORENSIC SCIENCE LABORATORIES UNDER ISO/IEC 17025: 2017
    Journal: International Journal of Advanced Research
    Date: 2021-06-30
    DOI: 10.21474/ijar01/12986
    Contributor: Fatma Cavus Yonar

Fu Xiaocong | Molecular Biology | Best Innovation Award

Published on by World Science Awards

Mr. Fu Xiaocong | Molecular Biology | Best Innovation Award

Shanghai Paisi Xin Biopharmaceutical Technology Co., Ltd. Malaysia

Dr. Xiaocong Fu is a highly accomplished Senior Tumor Immunology Researcher with more than a decade of experience in the development of cell therapy and gene/nucleic acid-based therapeutics. Currently based in Shanghai, he holds a PhD and has served in both academic and industrial roles, including as Founder of PSM Biotech and Associate Professor at Taylor’s University. His career encompasses a broad range of translational research activities with a strong focus on clinical immunology, drug mechanism validation, and precision oncology. He has published over 30 academic papers, with 13 as the first author in SCI-indexed journals, and holds more than nine personal invention patents. Dr. Fu is certified in GCP, CAP auditing, and biosafety regulations, with additional advisory roles in AI research and biotechnology projects. His multifaceted expertise includes immune function analysis, CAR-T/TCR-T method development, and organoid model systems, all of which reflect his dedication to innovation and real-world impact. His unique ability to combine clinical relevance with scientific discovery positions him as a leading figure in the field of tumor immunology and a strong candidate for prestigious innovation and research awards.

Professional Profile

Education

Dr. Xiaocong Fu holds a Doctorate in Tumor Immunology, which has laid the scientific foundation for his highly specialized career in immunotherapy research. In addition to his academic training in immunology, he pursued advanced studies in business and innovation management at the China Europe International Business School, equipping him with a strategic understanding of biotech commercialization and research leadership. This interdisciplinary educational background has uniquely positioned him to integrate laboratory innovation with real-world therapeutic applications. His formal training includes rigorous technical and regulatory coursework, exemplified by certifications in Good Clinical Practice (GCP) and clinical trial quality management. Dr. Fu has also completed specialized training in biosafety and laboratory quality systems, including certification from the Shanghai Biosafety Training and Assessment Program and the College of American Pathologists (CAP). These credentials have enabled him to oversee clinical laboratory standards and contribute to high-stakes regulatory audits and clinical research. His academic affiliation with Taylor’s University as an Associate Professor further demonstrates his commitment to continuous learning, academic mentorship, and scientific excellence. The combination of scientific rigor and managerial insight distinguishes Dr. Fu’s educational journey and reflects his preparedness to drive complex, multidisciplinary projects in immunology and therapeutic development.

Professional Experience

Dr. Xiaocong Fu’s professional journey spans more than a decade of progressive responsibility in both industry and academia, reflecting a strong blend of translational research and entrepreneurial leadership. From 2012 to 2019, he worked at Shanghai WuXi AppTec Co., Ltd., where he played a critical role in preclinical and clinical immunology research. His responsibilities included the development of orthotopic tumor models, pharmacokinetic/pharmacodynamic studies, immune function assays, and clinical biomarker validation. During this time, he built expertise in flow cytometry, immune subpopulation analysis, and organoid construction platforms. As Technical Director of the CAP Clinical Center, Dr. Fu successfully developed and validated multiple clinical methods, including those for CAR-T therapies and phosphorylation-related biomarker detection. His current roles include Founder of PSM Biotech, where he leads innovation in cell and gene therapy platforms, and Associate Professor at Taylor’s University, where he contributes to academic research and mentorship. He also serves as Vice President of the Jiangxi Chamber of Commerce and holds advisory roles with AI research institutes. Dr. Fu’s professional scope covers scientific innovation, quality control, clinical trial management, and biotech entrepreneurship, establishing him as a multifaceted leader in the biomedical and pharmaceutical research sectors.

Research Interests

Dr. Xiaocong Fu’s research interests lie at the forefront of tumor immunology, cell therapy development, and translational clinical science. His primary focus is on understanding the mechanisms of immune response in cancer, particularly through the development and validation of CAR-T and TCR-T therapies. He is deeply involved in immune-mediated killing analyses, including ADCC (antibody-dependent cellular cytotoxicity), CDC (complement-dependent cytotoxicity), ADCP (antibody-dependent cellular phagocytosis), and TLR (toll-like receptor) functions. Dr. Fu also explores immune phenotyping and biomarker discovery, especially in relation to hematological malignancies and solid tumors. Another key area of interest is the use of induced pluripotent stem cells (iPSCs) for disease modeling and drug response simulation, with his team constructing organoid platforms for more precise in vitro analyses. Additionally, he is passionate about integrating gene editing technologies such as CRISPR to develop immune cell-based models that mimic in vivo responses. Dr. Fu’s interests extend to clinical pharmacology, biomarker-based patient stratification, and receptor occupancy studies, all aimed at creating more effective, personalized therapeutic strategies. His research is inherently translational, bridging the gap between laboratory innovation and clinical application to improve patient outcomes in cancer immunotherapy.

Research Skills

Dr. Xiaocong Fu possesses a wide array of advanced research skills that make him a standout contributor in the field of tumor immunology and clinical translational research. He is proficient in both in vitro and in vivo assays, including the development of orthotopic tumor models and functional immune assays. He has mastered multiparameter flow cytometry and is capable of operating high-throughput cytometry instruments such as the BD Fortessa X-20 and Canto systems, applying panels with up to 18 colors. His skill set includes the quantitative analysis of intracellular and extracellular signaling molecules, using detection platforms like Cytometric Bead Array (CBA) and Meso Scale Discovery (MSD). Dr. Fu is experienced in gene editing using CRISPR/Cas9 technologies, having successfully developed monoclonal iPSCs with precise gene knock-ins/knockouts. In clinical pharmacology, he has validated several PK/PD methods for CAR-T therapies and phosphorylation biomarkers. His technical leadership extends to immunophenotyping of both lymphoid and myeloid subpopulations, receptor occupancy assays, and biomarker tracking. He is also adept at clinical laboratory quality systems, having contributed to CAP audits and biosafety program implementations. These diverse, high-level research skills have enabled him to lead multidisciplinary projects across discovery, validation, and clinical translation domains.

Awards and Honors

Throughout his career, Dr. Xiaocong Fu has received numerous accolades that highlight his commitment to excellence and innovation in biomedical research. While specific award titles are not listed in the provided profile, his recognition can be inferred from his leadership roles and scientific achievements. His appointment as an Associate Professor at Taylor’s University, a position typically awarded to individuals with significant academic contributions, underscores his research credibility. His selection as a CAP auditor and a GCP-certified clinical trial manager reflects the high level of trust regulatory and research bodies place in his judgment and technical competence. As the Founder of PSM Biotech, he has also been acknowledged for his entrepreneurial efforts in translating immunological science into therapeutic platforms. Moreover, his advisory role in AI-based scientific projects further demonstrates peer recognition of his interdisciplinary expertise. With over 13 first-author SCI publications and nine personal invention patents, Dr. Fu’s body of work stands as a testament to sustained scholarly and innovative output. These milestones serve as informal yet powerful recognitions of his contributions, suggesting that he is not only a subject matter expert but also a recognized leader in his field.

Conclusion

Dr. Xiaocong Fu exemplifies the fusion of scientific excellence, clinical relevance, and innovative thinking necessary to transform cancer therapy through immune system modulation. His rich educational background, expansive professional experience, and cutting-edge research portfolio position him at the forefront of biomedical innovation. From pioneering CAR-T and TCR-T therapies to constructing iPSC-based organoid models, his work covers the full spectrum of research from basic science to translational application. As a skilled researcher, technical leader, and biotech entrepreneur, Dr. Fu has developed and validated multiple clinical methodologies, driven discovery in tumor immunology, and fostered collaborations across academia, industry, and regulatory agencies. His research consistently addresses real-world challenges in oncology and immunotherapy, leveraging both molecular precision and systems-level insight. Although there is room to expand his visibility in global academic networks and enhance commercialization outcomes, Dr. Fu’s existing contributions are both impactful and future-focused. He is a model candidate for honors such as the Best Innovation Award in Research and represents the caliber of researcher who not only advances knowledge but also changes lives through science.

Mehwish Zehravi | Molecular Biology | Best Researcher Award

Published on by World Science Awards

Assist. Prof. Dr. Mehwish Zehravi | Molecular Biology | Best Researcher Award

Assistant Professor at Al-Tibri Medical College, Pakistan

Dr. Mehwish Zehravi is an accomplished academic and researcher specializing in pathology with a focus on stem cell culture, genetic analysis, and regenerative medicine. Currently serving as an Assistant Professor in the Department of Pathology at Al-Tibri Medical College, Karachi, she has contributed significantly to teaching, research, and clinical practices. Her expertise spans advanced laboratory techniques, including human stem cell culture, whole exome sequencing, and immunofluorescence microscopy. With a strong academic foundation, Dr. Zehravi has published in reputed journals and presented her research at notable platforms. Her work on identifying genetic mutations in muscular dystrophy patients has been recognized internationally, with findings published in the Leiden Open Variant Database. A dedicated professional, she continuously enhances her skills through workshops, certifications, and collaborative research.

Professional Profile

Education

Dr. Zehravi holds an M.Phil. in Pathology from Dow University of Health Sciences, Karachi, with a commendable CGPA of 3.48, achieved in 2020. She earned her M.B.B.S. from the same institution in 2012, securing a CGPA of 3.06. Her academic journey also includes pre-medical studies at B.A.M.M. P.E.C.H.S. Govt. College for Women, Karachi, and matriculation at St. Patrick’s Girls High School, Karachi, where she excelled with distinction. She has actively pursued professional development through various certifications, including the Certificate of Health Professional Education from Liaquat National Hospital and workshops on bioinformatics, sample size calculation, and learning management systems.

Professional Experience

Dr. Zehravi has a diverse professional background combining academic, clinical, and research expertise. Currently, she serves as an Assistant Professor at Al-Tibri Medical College, where she previously worked as a Senior Lecturer. Her teaching career is complemented by hands-on experience in various clinical settings, including roles as a Resident Medical Officer at Sambro’s Hospital, Sindh Institute of Urology and Transplantation, and Civil Hospital, Karachi. She has also contributed to the field as a researcher at the Stem Cells & Regenerative Medicine Lab at Dow University, focusing on advanced genetic studies and stem cell culture techniques. Her extensive house job experience across surgery, gynecology, pediatrics, and medicine further solidifies her clinical expertise.

Research Interests

Dr. Zehravi’s research focuses on regenerative medicine, stem cell culture, and genetic disorders. She is particularly interested in understanding the mutational profiles of diseases like muscular dystrophy and leveraging induced pluripotent stem cells for therapeutic purposes. Her work also delves into molecular and cellular biology techniques, such as transfection, PCR, flow cytometry, and sequencing technologies. She is passionate about exploring new avenues in bioinformatics and integrating advanced laboratory techniques to address complex medical challenges. Dr. Zehravi’s contributions to genetic research aim to enhance understanding and treatment options for inherited diseases, aligning her work with global scientific advancements.

Research Skills

Dr. Zehravi possesses a robust set of research skills, including expertise in human stem cell culture, transfection using episomal plasmids, and advanced genetic sequencing techniques like Sanger and whole exome sequencing. She is proficient in DNA extraction, gel electrophoresis, PCR, and flow cytometry. Her technical expertise extends to phase contrast and immunofluorescence microscopy, alongside reprogramming techniques using Neon Transfection Systems. Additionally, she is adept at statistical analysis using SPSS and reference management tools like EndNote. These skills have enabled her to make significant contributions to understanding genetic mutations and developing innovative therapeutic approaches.

Awards and Honors

Dr. Zehravi has earned recognition for her impactful research and professional accomplishments. Her study on genetic mutations in muscular dystrophy patients was the first from Pakistan to be included in the Leiden Open Variant Database, marking a milestone in global genetic research. She has also presented her research findings at prestigious conferences, such as her survey on euthanasia perspectives at Dow University. Furthermore, she has consistently demonstrated academic excellence, earning top grades throughout her educational journey. Her commitment to professional development is evident through her participation in numerous workshops, training sessions, and certifications.

Conclusion

Dr. Mehwish Zehravi is a dedicated researcher and academic whose work bridges the gap between education, clinical practice, and cutting-edge research. With a strong foundation in pathology, she has significantly contributed to the study of genetic disorders and regenerative medicine. Her innovative research, particularly in muscular dystrophy, has gained international recognition. Alongside her academic and research pursuits, Dr. Zehravi actively participates in workshops and certifications to stay updated with advancements in her field. With her exceptional skills and passion for medical research, Dr. Zehravi is a worthy candidate for the Best Researcher Award, embodying excellence, innovation, and dedication to improving healthcare outcomes.

Publication Top Notes

  1. Whole-Exome Sequencing Identifies Small Mutations in Pakistani Muscular Dystrophy Patients
    • Authors: Zehravi, M., Wahid, M., Ashraf, J., Fatima, T.
    • Year: 2021
    • Citations: 1
  2. Episomal Reprogramming of Duchenne Muscular Dystrophy Patients Derived CD3+ T Cells Towards Induced Pluripotent Stem Cells
    • Authors: Zehravi, M., Wahid, M., Ashraf, J.
    • Year: 2021
    • Citations: 1

 

Xiumin Wang | Molecular Biology | Women Researcher Award

Published on by World Science Awards

Prof. Dr. Xiumin Wang | Molecular Biology | Women Researcher Award

Researcher at Feed Research Institute, Chinese Academy of Agricultural Sciences, China

Dr. Wang Xiumin is a distinguished researcher currently serving at the Institute of Feed Research, Chinese Academy of Agricultural Sciences (CAAS). With a profound academic background and extensive research experience in the field of plant pathology and microbial resistance, Dr. Wang has become a leading figure in her field. Over her career, she has focused on microbial resistance, antibacterial peptides, and the development of therapeutic strategies to combat infectious diseases, especially those involving multi-drug resistant pathogens. Dr. Wang’s work has been instrumental in bridging the gap between fundamental microbiology and applied agricultural practices, contributing to the development of feed-related solutions and sustainable agricultural practices. Her research is widely recognized through numerous publications in prestigious scientific journals, where she has co-authored over 80 papers.

Professional Profile

Education:

Dr. Wang Xiumin obtained her Ph.D. in Plant Pathology from Northwest Agriculture & Forestry University in 2006, after completing her Master’s and Bachelor’s degrees at the same institution in 2003 and 2000, respectively. Her academic training equipped her with in-depth knowledge in plant protection and pathology, laying a strong foundation for her career in agricultural sciences and microbiology. Her academic journey enabled her to focus on plant diseases, microbiology, and biotechnology, advancing her research in combating bacterial resistance in agricultural systems.

Professional Experience:

Dr. Wang Xiumin has accumulated extensive professional experience across various prestigious institutions. From 2006 to 2009, she worked as a Postdoctoral Fellow at Beijing Forestry University, engaging in critical research in plant pathology. Between 2009 and 2013, she served as an Assistant Researcher at the Feed Research Institute of CAAS. Since 2013, she has held the position of Associate Researcher at the same institute. In 2019-2020, she visited the School of Chemistry and Molecular Biosciences at the University of Queensland, further enhancing her expertise in molecular biosciences and plant pathology. Throughout her career, Dr. Wang has continually advanced her research while mentoring emerging scientists in her field.

Research Interests:

Dr. Wang’s research interests lie at the intersection of microbial resistance, plant pathology, and feed-related research. Her work primarily focuses on antibacterial peptides, microbial resistance mechanisms, and the development of therapeutic proteins and peptides. She has also contributed to studies on food safety, including the detoxification of mycotoxins, and has explored the therapeutic potential of marine peptides for bacterial infections. Dr. Wang’s research in microbial resistance and peptide-based therapeutics is crucial for advancing sustainable agricultural and clinical practices, particularly in the context of combating drug-resistant pathogens in both animals and humans.

Research Skills:

Dr. Wang Xiumin is highly skilled in a variety of research techniques including molecular biology, microbiology, and biotechnology. She has experience in the design and application of antibacterial peptides, the isolation and characterization of bioactive compounds, and the assessment of microbial resistance mechanisms. Her expertise also extends to advanced techniques in molecular cloning, protein expression, and peptide synthesis. Additionally, Dr. Wang is adept at using in vitro and in vivo models to study the effects of therapeutic peptides and other compounds on microbial infections. Her diverse skill set has been pivotal in advancing her research projects and making significant contributions to agricultural and health sciences.

Awards and Honors:

Dr. Wang Xiumin has received several accolades for her outstanding contributions to the field of plant pathology and microbiology. She has been recognized for her innovative research in microbial resistance and peptide-based therapeutics, receiving awards from various scientific and agricultural bodies in China. Her significant publications in high-impact journals such as Science of the Total Environment, Journal of Medicinal Chemistry, and Food Chemistry have cemented her reputation as a leading researcher in her field. Additionally, her collaborative work with international research institutes has earned her several fellowships, including her research visit to the University of Queensland, further acknowledging her impact on global agricultural science and medical microbiology.

Conclusion

Dr. Wang Xiumin demonstrates a strong and well-rounded research profile, with impressive publications and a proven ability to address complex issues in plant pathology and antimicrobial resistance. His work is highly relevant and impactful in agricultural and biomedical fields. His contributions place him as a strong candidate for the Excellence in Research Award. Expanding his industry collaborations and mentoring roles would elevate his profile further, making him an even more influential figure in his field.

Publication Top Notes

  1. Application of Lactobacillus plantarum and Pediococcus lactis on Lipid Metabolism, Anti-Inflammatory, and Fecal Microbiota in Cats
    • Authors: Shukun Liang, Xinshu Gu, Jintao Sun, Xiumin Wang, Hui Tao, Zhenlong Wang, Yougang Zhong, Jinquan Wang, Bing Han
    • Year: 2024
    • DOI: 10.3390/microorganisms12122446
  2. Application of Network Pharmacology, Molecular Docking, and In Vitro Experimental Evaluation to Decipher the Anti-Inflammatory Mechanisms of Cirsium japonicum
    • Authors: Jiaxue Wang, Hui Tao, Zhenlong Wang, Wei An, Ya Zhao, Bing Han, Jinquan Wang, Xiuzhu Sun, Xiumin Wang
    • Year: 2024
    • DOI: 10.3390/app14219687
  3. Simultaneous Degradation of AFB1 and ZEN by CotA Laccase from Bacillus subtilis ZJ-2019-1 in the Mediator-Assisted or Immobilization System
    • Authors: Boquan Gao, Wei An, Jianwen Wu, Xiumin Wang, Bing Han, Hui Tao, Jie Liu, Zhenlong Wang, Jinquan Wang
    • Year: 2024
    • DOI: 10.3390/toxins16100445
  4. Allergies to Allergens from Cats and Dogs: A Review and Update on Sources, Pathogenesis, and Strategies
    • Authors: Wei An, Ting Li, Xinya Tian, Xiaoxin Fu, Chunxiao Li, Zhenlong Wang, Jinquan Wang, Xiumin Wang
    • Year: 2024
    • DOI: 10.3390/ijms251910520
  5. Bacillus subtilis Simultaneously Detoxified Aflatoxin B1 and Zearalenone
    • Authors: Jianwen Wu, Zhenlong Wang, Wei An, Boquan Gao, Chunxiao Li, Bing Han, Hui Tao, Jinquan Wang, Xiumin Wang, Huanrong Li
    • Year: 2024
    • DOI: 10.3390/app14041589
  6. The Effect of Lactobacillus plantarum on the Fecal Microbiota, Short Chain Fatty Acids, Odorous Substances, and Blood Biochemical Indices of Cats
    • Authors: Bing Han, Shukun Liang, Jintao Sun, Hui Tao, Zhenlong Wang, Baosheng Liu, Xiumin Wang, Jie Liu, Jinquan Wang
    • Year: 2024
    • DOI: 10.3390/microorganisms12010091
  7. Comparison Study of Two Fumonisin-Degrading Enzymes for Detoxification in Piglets
    • Authors: Zhenlong Wang, Zonghao Lv, Tibor Czabany, Veronika Nagl, Rudolf Krska, Xiumin Wang, Bing Han, Hui Tao, Jie Liu, Jinquan Wang
    • Year: 2023
    • DOI: 10.3390/toxins16010003
  8. The Effect of Duck Bile Acid Extract on the Fecal Microbiota, Short Chain Fatty Acids, Fat Digestibility and Blood Biochemical Indices in Cats
    • Authors: Bing Han, Peng Zhao, Shukun Liang, Zhenlong Wang, Hui Tao, Xiumin Wang, Jie Liu, Jinquan Wang
    • Year: 2023
    • DOI: 10.3390/app13179713
  9. A Screening Model of Antibacterial Agents Based on Escherichia coli Cell-Division Protein
    • Authors: Qiuyu Fan, Jianwen Wu, Bolin Xi, Chunxiao Li, Xiumin Wang, Huanrong Li
    • Year: 2023
    • DOI: 10.3390/app13074493
  10. Mini-Review: Antibiotic-Resistant Escherichia coli from Farm Animal-Associated Sources
    • Authors: ChunMing Xu, Lingqiang Kong, Yonghong Liao, Yuan Tian, Qi Wu, Haosi Liu, Xiumin Wang
    • Year: 2022
    • DOI: 10.3390/antibiotics11111535